Mesoblast MEOBF
NASDAQ MEOBF
$1.90 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Mesoblast (MEOBF) Non-Current Assets (2014 - 2026)

Mesoblast's (MEOBF) quarterly Non-Current Assets came in at $575.6 million in Q2 2026, down 0.82% year-over-year from $580.3 million in Q2 2025, and down 0.73% quarter-over-quarter from $579.8 million in Q4 2025.

Analysis

Mesoblast (MEOBF) Non-Current Assets (2014 - 2026) Analysis & Trends

Mesoblast has disclosed Non-Current Assets across 13 years of filings, most recently posting $575.6 million for Q2 2026.

  • In Q2 2026, Non-Current Assets fell 0.82% year-over-year to $575.6 million; the TTM figure through Jun 2026 stood at $575.6 million (down 0.82% YoY), while the FY2026 annual figure was $575.6 million, down 0.82% from the prior year.
  • Non-Current Assets came in at $575.6 million for Q2 2026 at Mesoblast, down from $579.8 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $593.6 million in Q1 2022 to a low of $575.6 million in Q2 2026.
  • Average Non-Current Assets over 5 years is $585.9 million, with a median of $586.4 million recorded in 2023.
  • Year-over-year, Non-Current Assets retreated 0.96% in 2022 and decreased 0.25% in 2024.
  • Over 5 years, Non-Current Assets stood at $589.9 million in 2022, then dropped by 0.81% to $585.1 million in 2023, then decreased by 0.25% to $583.6 million in 2024, then slipped by 0.65% to $579.8 million in 2025, then decreased by 0.73% to $575.6 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $575.6 million in Q2 2026, $579.8 million in Q4 2025, and $580.3 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Krystal Biotech 10.27 Bn 9.43 Bn 112.79 Mn 441.00 Mn
2 CRISPR Therapeutics AG 5.17 Bn 5.17 Bn - 279.00 Mn
3 Iovance Biotherapeutics 3.79 Bn 3.49 Bn 55.72 Mn 451.27 Mn
4 Legend Biotech 3.68 Bn 2.71 Bn 251.50 Mn 523.50 Mn
5 uniQure 3.05 Bn 3.05 Bn 5.49 Mn 150.83 Mn
6 Beam Therapeutics 2.65 Bn 2.65 Bn - 207.76 Mn
7 Precigen 2.44 Bn 2.44 Bn 52.17 Mn 35.91 Mn
8 Sarepta Therapeutics 2.33 Bn 1.53 Bn 251.87 Mn 964.69 Mn
9 Vericel 1.99 Bn 1.83 Bn 56.40 Mn 238.14 Mn
10 Mesoblast 246.02 Mn 143.11 Mn - 575.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 575.59 Mn
Dec 31, 2025 579.82 Mn
Jun 30, 2025 580.33 Mn
Dec 31, 2024 583.64 Mn
Jun 30, 2024 582.69 Mn
Dec 31, 2023 585.13 Mn
Jun 30, 2023 587.76 Mn
Mar 31, 2023 589.08 Mn
Dec 31, 2022 589.93 Mn
Sep 30, 2022 591.54 Mn
Jun 30, 2022 592.31 Mn
Mar 31, 2022 593.56 Mn
Dec 31, 2021 595.64 Mn
Sep 30, 2021 595.60 Mn
Jun 30, 2021 596.49 Mn
Mar 31, 2021 596.36 Mn
Dec 31, 2020 596.85 Mn
Sep 30, 2020 596.84 Mn
Jun 30, 2020 597.05 Mn
Mar 31, 2020 596.40 Mn